Table 3 England (1999 to 2011): rate ratios for respiratory and non-respiratory tuberculosis (TB) for people with immune-mediated diseases

Addison's disease

6.5 (4.4 to 9.4)

33.0 (25.1 to 42.6)

Ankylosing spondylitis

4.6 (3.4 to 6.0)

4.7 (2.8 to 7.3)

Autoimmune hemolytic anemia

7.2 (4.6 to 10.7)

4.3 (1.4 to 10.1)

Chronic active hepatitis

3.0 (1.0 to 7.0)

9.3 (3.7 to 19.3)

Crohn's disease

3.3 (2.8 to 3.9)

5.7 (4.6 to 6.9)

Coeliac disease

2.8 (2.2 to 3.7)

1.6 (0.9 to 2.7)

Dermatomyositis

9.6 (4.2 to 19.0)

5.3 (0.6 to 19.2)

Polymyositis

8.7 (4.8 to 14.7)

8.7 (3.2 to 18.9)

Goodpasture's syndrome

11.3 (3.1 to 29.0)

15.0 (1.8 to 54.4)

Hashimoto's thyroiditis

2.9 (1.2 to 6.0)

1.8 (0.2 to 6.5)

Idiopathic thrombocytopenia purpura

3.8 (2.7 to 5.1)

5.3 (3.4 to 8.0)

Multiple sclerosis

1.0 (0.6 to 1.4)

0.8 (0.4 to 1.5)

Myasthenia gravis

3.1 (1.9 to 5.0)

2.5 (0.8 to 5.9)

Myxedema

1.6 (1.5 to 1.8)

2.0 (1.7 to 2.2)

Pemphigus

1.1 (0.0 to 6.2)

6.2 (0.8 to 22.3)

Pemphigoid

2.3 (1.2 to 4.1)

3.1 (1.0 to 7.3)

Pernicious anemia

2.2 (1.6 to 2.8)

2.4 (1.4 to 3.7)

Polyarteritis nodosa

8.6 (3.7 to 16.9)

3.0 (0.1 to 16.9)

Primary biliary cirrhosis

4.0 (2.1 to 6.8)

7.9 (4.1 to 13.8)

Psoriasis

2.9 (2.4 to 3.5)

2.5 (1.8 to 3.4)

Rheumatoid arthritis

3.6 (3.2 to 3.9)

3.2 (2.7 to 3.8)

Scleroderma

6.2 (4.0 to 9.1)

3.8 (1.5 to 7.8)

Sjögren's syndrome

4.8 (3.2 to 6.9)

4.8 (2.5 to 8.2)

Systemic lupus erythematosus

8.4 (6.6 to 10.5)

14.6 (11.3 to 18.7)

Thyrotoxicosis

2.3 (1.9 to 2.8)

2.4 (1.7 to 3.2)

Ulcerative colitis

1.7 (1.4 to 2.0)

1.8 (1.4 to 2.4)